News

Hidden reactivation, active immunity: Mapping the immune response to HSV-2

Hidden reactivation, active immunity: Mapping the immune response to HSV-2

From the Lund Lab, Vaccine and Infectious Disease Division
Science SpotlightJanuary 28, 2026
Making memories with Shingrix

Making memories with Shingrix

From the Ford and Koelle labs of the Cancer Consortium, in collaboration with the Benaroya Research Institute
Science SpotlightApril 16, 2025
Driver’s ed: watching HSV co-infection and recombination in vivo

Driver’s ed: watching HSV co-infection and recombination in vivo

From the Jerome Lab, Vaccine & Infectious Disease Division
Science SpotlightNovember 22, 2024
Engineered HSV can trigger genetic chain reaction, rejigger HSV genes during co-infection

Engineered HSV can trigger genetic chain reaction, rejigger HSV genes during co-infection

Proof-of-concept work raises hope that ‘gene drive’ could one day form basis of curative gene therapy for herpes
Hutch NewsOctober 11, 2024
El momento en que se administra la TAR para el VIH es más importante de lo que imaginábamos

El momento en que se administra la TAR para el VIH es más importante de lo que imaginábamos

De los grupos de los doctores Edlefsen y Frenkel, Consorcio Oncológico
Science SpotlightAugust 21, 2024
Herpes cure with gene editing makes progress in laboratory studies

Herpes cure with gene editing makes progress in laboratory studies

Fred Hutch virologists eliminated at least 90% of HSV-1 in preclinical models of oral and genital herpes and reduced viral shedding in a study published in Nature Communications
News ReleasesMay 13, 2024
In the crosshairs:  herpesvirus 6B as a potential cause of idiopathic pneumonia

In the crosshairs: herpesvirus 6B as a potential cause of idiopathic pneumonia

From the Hill and Boeckh groups, Vaccine and Infectious Disease and Clinical Research Divisions
Science SpotlightFebruary 21, 2024
When a single amino acid makes all the difference

When a single amino acid makes all the difference

From the Geballe Lab, Human Biology Division
Science SpotlightNovember 20, 2023
Switching from KSHV latency to lytic replication

Switching from KSHV latency to lytic replication

From the Geballe lab, Human Biology Division & Cancer Consortium
Science SpotlightMarch 20, 2023
Researching herpes treatments with 'skin-on-chip' technology

Researching herpes treatments with 'skin-on-chip' technology

Experimental device grows human skin, infects and treats it; could advance disease modeling in labs
Hutch NewsOctober 19, 2022
A new take on having skin in the game

A new take on having skin in the game

From the Zhu lab, Vaccine and Infectious Disease Division
Science SpotlightOctober 17, 2022
Researchers  refine experimental gene therapy for herpes

Researchers refine experimental gene therapy for herpes

Treatment sharply reduced viral shedding in laboratory mice
Hutch NewsSeptember 26, 2022
What viruses can teach us about ourselves

What viruses can teach us about ourselves

Dr. Daphne Avgousti studies viruses that can give us a window into fundamental human biology that we can use to improve our health
Hutch NewsAugust 29, 2022
A unique population of mucosal Tregs respond to local viral infection

A unique population of mucosal Tregs respond to local viral infection

From the Lund and Prlic labs, Vaccine and Infectious Disease Division
Science SpotlightAugust 15, 2022
Sleuthing the immune system’s mysterious T-regs

Sleuthing the immune system’s mysterious T-regs

Dr. Jennifer Lund probes why regulatory T cells show up when trouble comes around
Hutch NewsDecember 10, 2021
Tissue localization shapes antiviral T cell dynamics

Tissue localization shapes antiviral T cell dynamics

From the Prlic and Lund labs, Vaccine and Infectious Disease Division
Science SpotlightJuly 19, 2021